[9] In this regard, CD19-directed CAR treatment of patients resulted in persistence of immunological memory, trafficking to the tumor sites, and non-HLA-restricted anti-tumor activity, which led to tumor regression and, in most of the patients, complete remission. Here, CD19 is linked to neoplasm.